 Connection
Christina Chambers to Depressive Disorder
This is a "connection" page, showing publications Christina Chambers has written about Depressive Disorder.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.857 |
|
|
|
-
Alwan S, Friedman JM, Chambers C. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence. CNS Drugs. 2016 Jun; 30(6):499-515.
Score: 0.383
-
Heinonen EW, Kao K, Mattson SN, Chambers CD. Cognitive Outcomes of Children Exposed to Selective Serotonin Reuptake Inhibitors Through Breast Milk. JAMA Netw Open. 2025 11 03; 8(11):e2544989.
Score: 0.184
-
Palmsten K, Chambers CD, Wells A, Bandoli G. Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage. Paediatr Perinat Epidemiol. 2020 09; 34(5):597-606.
Score: 0.125
-
Bérard A, Sheehy O, Zhao JP, Chambers C, Roth M, Bozzo P, Johnson D, Kao K, Lavigne S, Wolfe L, Quinn D, Dieter K. Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy. Eur Neuropsychopharmacol. 2019 07; 29(7):803-812.
Score: 0.118
-
Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006 Feb 09; 354(6):579-87.
Score: 0.047
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|